Lecture Series

E. F. F. Copp Lecture Series

The California Metabolic Research Foundation provided  honoraria for speakers participate in this lecture series named after the foundation’s founder, Dr. E. F. F. Copp. These speakers represented the “who’s who” of leading diabetes research.  The purpose was to give professional diabetologists in Southern California exposure to the various specialists in foreign countries.

The lecture series was co-sponsored by the American Diabetes Association, Southern California Affiliate, Inc. and the California Metabolic Research Foundation.  The majority of the 19 lectures were held at the prestigious Los Angeles County Medical Association between 1971 and 1986.

Lecturers and presentations included:

MECHANISMS OF AUTOIMMUNITY IN THE DEVELOPMENT OF INSULIN-DEPENDENT DIABETES – FUTURE PROSPECTS OF PREVENTION
Åke Lernmark, MD, PhD
Hagedorn Research Laboratory, Gentofte, Denmark
May 22, 1986

ASPECTS OF NORMAL AND DISTURBED BETA-CELL FUNCTION IN MOUSE MODELS OF DIABETES
Inge-Bert Täljedal, MD
Department of Histology and Cell Biology
University of Umeå, Sweden
May 8, 1985

IS NON INSULIN DEPENDENT DIABETES A DESEASE OF HORMONE RESISTANCE?
Erol Cerasi, MD, PhD
The Hebrew University of Hadassah Medical Center
Jerusalem, Israel
May 17, 1984

THE PATHOPHYSIOLOGICAL BACKGROUND AND TREATMENT OF DIABETIC COMA
Werner K. Waldhäuser, MD
Division of Clinical Endocrinology & Diabetes Mellitus
First Department of Internal Medicine
University of Vienna Medical School, Austria
March 24, 1983

TREATING DIABETIC NEPHROPATHY IN THE 80’S: THE CASE FOR REVERSIBILITY
Carl Erik Mogensen, MD
Second University Clinic of Internal Medicine
University of Aarhus, Denmark
June 8, 1982

PATHOGENETIC HETEROGENEITY OF DIABETES: WHAT IS ITS CLINICAL AND PRACTICAL SIGNIFICANCE?
Albert E. Renold, MD
Institut de Biochemie clinique
University of Geneva Medical School, Switzerland
May 21, 1981

THE CAUSES OF DIABETES AND ITS COMPLICATIONS
David Pyke, MD, FRCP
King’s College Hospital
London, England
May 22, 1980

PHYSIOLOGIC DELIVERY OF INSULIN IN THE TREATMENT OF DIABETES MELLITUS
Georges Tchobroutsky, MD
Department of Diabetology
Paris Hospitals, France
November 29, 1979

THE NEW ALIMENTARY HORMONAL PEPTIDES – A DIABETOLOGIST’S VIEW
Stephen R. Bloom, MD
Royal Postgraduate Medical School
University of London, England
November 10, 1978

THE EVOLUTION OF MATURITY ONSET DIABETES AND TEH INFLUENCE OF DRUG INTERVENTION
Harry Keen, MD
Guy’s Hospital Medical School
London Bridge, England
November 10, 1977

CURRENT CONCEPTS OF INSULIN ACTION: RECEPTORS, MEMBRANE FUNCTION, AND THE QUEST FOR A SECOND MESSENGER
Karl Dietrich Hipp, MD
Diabetes Research Unit
Munich, West Germany
March 16, 1977

PATHOGENETIC FACTORS IN THE DEVELOPMENT OF THE LONG TERM DIABETIC SYNDROME
Knud Lundback, MD, PhD
Second University Clinic of Internal Medicine
University of Aarhus, Denmark
March 13, 1976

VIRUSES AND SOME OTHER FACTORS IN THE ETIOLOGY OF HUMAN DIABETES
Keith W. Taylor, MD, PhD
Department of Biochemistry
University of Sussex, Brighton, England
March 22, 1975

FURTHER STUDIES ON THE PATHOGENESIS OF DIABETES IN MAN
Rolf Luft, MD, PhD
Karolinska Institute
Stockholm, Sweden
March 12, 1974

MONOCOMPONENT INSULIN AND ITS CLINICAL IMPLICATIONS
Jørgen Schlichtkrull, DSc
Novo Research Institute
Copenhagen, Denmark
March 16, 1973

INSULIN AND FAT METABOLISM
Philip J. Randle, MD, PhD
Department of Biochemistry, Medical School
University of Bristol, England
April 20, 1972

STUDIES ON INSULIN BIOSYNTHESIS
Donald D. Steiner, MD
Department of Biochemistry
University of Chicago
May 6, 1971

PERMEABILITY OF THE BETA CELL AND THE DIABETES PROBLEM
Arnold Lazaro, MD, PhD
Department of Anatomy, Medical School
University of Minnesota
March 25, 1971

INSULIN ACTION ON CELL METABOLISM AND INTERRELATIONSHIP TO ADENYL CYCLASE AND ION TRANSPORT
Otto Walass, Md, Dr. Med.
Institute for Medical Biochemistry
University of Oslo, Norway
February 25, 1971